Stereotactic body radiation therapy for inoperable localized kidney cancer

Stereotactic body radiation therapy for inoperable localized kidney cancer

Purpose of the study: to evaluate the overall survival and local control in patients with inoperable kidney cancer treated with stereotactic body radiotherapy (SBRT).Material and Methods. From 2011 to 2021, 42 patients with histologically verified kidney cancer underwent SBRT to a total dose ranging...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zh. E. Sabelnikova, M. M. Sarycheva, E. Ya. Mozerova, A. V. Vazhenin
Format:	Article
Language:	Russian
Published:	Russian Academy of Sciences, Tomsk National Research Medical Center 2023-05-01
Series:	Сибирский онкологический журнал
Subjects:	stereotactic radiation therapy kidney cancer recurrent kidney cancer
Online Access:	https://www.siboncoj.ru/jour/article/view/2541
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Stereotactic ablative radiotherapy for primary kidney cancer – An international patterns of practice survey
by: Katherine Taplin, et al.
Published: (2025-01-01)

The surgical treatment of a patient with localized renal cancer and chronic renal failure following a course of stereotactic radiotherapy
by: G. V. Gilivanova, et al.
Published: (2025-03-01)

Sharing Mono-Institutional Experience of Treating Pancreatic Cancer with Stereotactic Body Radiation Therapy (SBRT)
by: Asmara Waheed, et al.
Published: (2024-10-01)

Iodine-125 brachytherapy and robotic stereotactic radiotherapy — treatment options for patients with localized prostate cancer
by: E. A. Kiprijanov, et al.
Published: (2021-12-01)

NEUTRON RADIATION THERAPY IN THE TREATMENT OF RECURRENT HIGH-GRADE GLIOMA
by: M. M. Sarycheva, et al.
Published: (2021-05-01)

Stereotactic Body Radiotherapy for Medically Inoperable Malignant Lung Tumor with Respiratory Gating: A Retrospective Observational Study from Tertiary Cancer Center
by: M. N. Arunkumar, et al.
Published: (2025-04-01)

Stereotactic Body Radiation Therapy for Oligometastatic Recurrent Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study From a Single Tertiary Center
by: Atsuto Katano, et al.
Published: (2025-06-01)

Development and validation of a nomogram for local control prediction in lung cancer patients treated with stereotactic body radiation therapy based on clinical, dosimetric, and inflammation-related parameters
by: Bao-Tian Huang, et al.
Published: (2025-07-01)

Demystifying CyberKnife Stereotactic Body Radiation Therapy for Interventional Radiologists
by: Azzam Khankan, et al.
Published: (2017-07-01)

The efficacy of Stereotactic body radiation therapy and the impact of systemic treatments in oligometastatic patients from prostate cancer
by: Ciro Franzese, et al.
Published: (2018-09-01)

Target Localization Accuracy of Image Registrations in Cone Beam Computed Tomography‐Guided Stereotactic Body Radiation Therapy for Lung Cancer
by: Seong Soon Jang, et al.
Published: (2025-08-01)

Analysis of standard vs dose-escalated stereotactic body radiation therapy in localized prostate cancer: a comparative evaluation of survival outcomes
by: Bichun Xu, et al.
Published: (2025-08-01)

Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival
by: Jared R. Robbins, et al.
Published: (2019-03-01)

Stereotactic body radiation therapy in primary liver tumor: Local control, outcomes and toxicities
by: Ludovic Hernandez, et al.
Published: (2025-01-01)

Radiotherapy quality assurance program of ongoing clinical trial using stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a dummy run study of a prospective, randomized, multicenter phase III trial (KGOG 3064/KROG 2204)
by: Sangjoon Park, et al.
Published: (2025-08-01)

Prognostic analysis of helical tomotherapy stereotactic body radiotherapy in multiple primary or second primary lung cancers
by: Jintao Ma, et al.
Published: (2025-01-01)

Stereotactic body radiotherapy for early glottic cancers: Is this “The Way”?
by: Jennifer Le Guévelou, et al.
Published: (2025-07-01)

Prognostic Impact of Tumor Solid Components in Stereotactic Body Radiotherapy for Clinical Stage Tis–1N0M0 Lung Cancer
by: Junki Fukuda, et al.
Published: (2025-06-01)

Biological sex representation and reporting in stereotactic body radiotherapy for kidney cancer: A review of clinical studies
by: Sylvia Nwokolo, et al.
Published: (2025-11-01)

Effectiveness of individual audio-visual coaching, respiratory modulated stereotactic body radiotherapy for localized hepatocellular carcinoma: Analysis of 29 cases from a single academic radiotherapy center
by: Liang-Cheng Chen, et al.
Published: (2021-01-01)

Role of functional mapping on Gallium-68 perfusion positron emission tomography and computed tomographic imaging (PET/CT) to assess the risk of long-term radiation-induced lung toxicity after stereotactic body radiation therapy
by: François Lucia, et al.
Published: (2025-04-01)

Oligometastatic granulosa cell tumor treated with stereotactic body radiation therapy with a radiographic and tumor marker response
by: Madeline Petty, et al.
Published: (2025-04-01)

Effectiveness of Combination Therapy of Stereotactic Body Radiation Therapy with Lenvatinib in Advanced Hepatocellular Carcinoma
by: Alifia Sabira Putri, et al.
Published: (2025-08-01)

Impact of ground-glass component on prognosis in early-stage lung cancer treated with stereotactic body radiotherapy via Helical Tomotherapy
by: Jintao Ma, et al.
Published: (2024-12-01)

CyberKnife Stereotactic Radiosurgery System for Pituitary Tumors and Pulmonary Cancer Bone Metastases: Initiating a New Chapter in Stereotactic Radiotherapy
by: CHENG Weishi, et al.
Published: (2025-02-01)

Pattern of recurrence after fractionated stereotactic reirradiation in adult glioblastoma
by: Agathe Margulies, et al.
Published: (2025-02-01)

Difficulties associated with differential diagnosis between brain metastases and foci of necrosis resulted from stereotactic radiotherapy (case report and literature review)
by: А. V. Nazarenko, et al.
Published: (2019-10-01)

Stereotactic Ablative Radiation Therapy in 3 Fractions Induces a Favorable Systemic Immune Cell Profiling in Prostate Cancer Patients
by: Belinda Palermo, et al.
Published: (2023-12-01)

Experience of stereotactic radiation therapy and radiosurgical treatment of metastatic vertebral tumors
by: O. I. Kit, et al.
Published: (2024-05-01)

Planned Liver Stereotactic Body Radiotherapy for Residual Colorectal Cancer Liver Metastases After Surgery: A Single-Arm Retrospective Study
by: Sixuan Li, et al.
Published: (2025-06-01)

Phantom kidney at angionephroscintigraphy
by: S. P. Mironov, et al.
Published: (2016-03-01)

Stereotactic body radiotherapy for single and multiple early-stage non-small cell lung cancer in patients aged ≥ 80 years
by: Samuel M. Vorbach, et al.
Published: (2025-07-01)

Delayed Abscopal Response 3 Years After Robotic Stereotactic Body Radiation Therapy for Renal Cell Carcinoma: A Case Report
by: Zhe Chen, et al.
Published: (2025-05-01)

Feasibility of Mediastinal Radiation Use in HeartMate 3 LVAD Recipients with Cancer
by: Nausharwan Butt, et al.
Published: (2023-01-01)

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection
by: Angelika Bilger, et al.
Published: (2018-06-01)

Low-Burden Oligometastatic Disease of the Lung Treated with Robotic Stereotactic Ablative Radiotherapy: A Retrospective Study
by: Anna Zygogianni, et al.
Published: (2025-02-01)

Radiation Treatment of Synchronous Gynaecologic Cancer: a Clinical Case
by: P. A. Lushnikova, et al.
Published: (2020-11-01)

An interpretable ensemble model combining handcrafted radiomics and deep learning for predicting the overall survival of hepatocellular carcinoma patients after stereotactic body radiation therapy
by: Yi Chen, et al.
Published: (2025-02-01)

A Comparison of Stereotactic Radiation Therapy in Elderly Patients with Central or Peripheral Stage I-II (T1-3 N0 M0) Non-Small Cell Lung Cancer
by: Ji X, et al.
Published: (2024-11-01)

Local recurrence and radionecrosis after single-isocenter multiple targets stereotactic radiotherapy for brain metastases
by: J. A. Crouzen, et al.
Published: (2025-05-01)